FDA expands use of kidney cancer drug belzutifan

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier-stage kidney cancers in ...

Researcher finds gender gap in kidney transplant referrals

Female patients with kidney failure are significantly less likely to be referred to a transplant center for assessment, according to a new study from ICES, London Health Sciences Center Research Institute (LHSCRI) and Western ...

Hormone impacts red blood cell production in anemia

Northwestern Medicine scientists have discovered that the hormone FGF23 reduces the production of red blood cells and may contribute to the development of anemia in chronic kidney disease, according to a recent study published ...

page 6 from 28